{
    "applicationNumber": "BR 11 2021 020525-0",
    "filingDate": "16/04/2020",
    "grantDate": null,
    "title": "AGENTE TERAP\u00caUTICO PARA C\u00c2NCER UROL\u00d3GICO QUE SE CARACTERIZA POR SER ADMINISTRADO COM INIBIDOR DE IL-6 E INIBIDOR DE CCR2 EM COMBINA\u00c7\u00c3O",
    "nationalPhaseDate": [
        "13/10/2021"
    ],
    "internationalApplication": {
        "pctNumber": "PCT JP2020/016652",
        "pctDate": "16/04/2020",
        "wipoNumber": null,
        "wipoDate": null
    },
    "priorityClaims": [
        {
            "countryCode": "JP",
            "priorityNumber": "2019-078928",
            "priorityDate": "17/04/2019"
        }
    ],
    "events": [
        {
            "code": "1.1",
            "description": "Publica\u00e7\u00e3o Internacional \u2013 PCT. Apresenta\u00e7\u00e3o de peti\u00e7\u00e3o de requerimento de entrada na fase nacional",
            "bulletinNumber ": "2651"
        },
        {
            "code": "1.3",
            "description": "Notifica\u00e7\u00e3o - Fase Nacional - PCT",
            "bulletinNumber ": "2658"
        }
    ],
    "inventors": [
        "HIROAKI HONDA",
        "KOHEI KOBATAKE"
    ],
    "holders": [
        300536,
        86875,
        165100
    ],
    "ipcCodes": [
        "A61P 35/00",
        "A61K 39/395",
        "A61P 13/00",
        "A61P 43/00",
        "A61K 31/28",
        "A61P 13/12",
        "A61P 13/08",
        "A61K 45/06",
        "A61P 13/10"
    ]
}